Comparison of postweaning bovine respiratory disease treatment rates between non-vaccinated control beef calves and calves variably primed and boosted using commercially available bovine coronavirus vaccines.

Objective: Bovine respiratory disease (BRD) and overall postweaning treatment rates were compared among 3 groups of calves either differentially primed and boosted with commercially available bovine coronavirus (BCoV) vaccine or not vaccinated against BCoV. Animals: Commercial heifer and steer beef calves born in April and May 2022. Procedure: In June 2022, calves were randomly enrolled into 3 treatment groups. Those in 2 groups [V1 (n = 160) and V2 (n = 160)] were administered a mucosal priming dose of 1 of 2 commercial BCoV vaccines; those in the 3rd group [CTL (n = 151)] were unvaccinated against BCoV. The V1 and V2 groups were boosted by intramuscular injection pre-weaning with the same vaccine used for priming. Weaning occurred 3 wk after the last preweaning processing day. Ranch staff used a BRD case definition provided by their herd veterinarian to identify, treat, and record treatments for 45 d post-weaning. Results: Postweaning BRD treatment rates for V1, V2, and CTL were 7%, 9%, and 14%, respectively. The CTL calves had 2.2× greater odds of receiving treatment for BRD than V1 calves. There were no differences in odds of treatment between CTL and V2 calves or V1 and V2 calves. Conclusion: In a herd with previously diagnosed BCoV BRD cases, prime-boost vaccination of calves is associated with a difference in odds of BRD treatment post-weaning compared to not vaccinating calves against BCoV. Clinical relevance: Prime-boost vaccination with commercial BCoV vaccine may be an important management tool for herds with known BCoV BRD outbreaks.

Comparaison des taux de traitement des maladies respiratoires bovines après le sevrage entre des veaux de boucherie témoins non vaccinés et des veaux vaccinés amorce-rappel de manière variable à l'aide de vaccins contre le coronavirus bovin commercialement disponibles. Objectif: La maladie respiratoire bovine (BRD) et les taux globaux de traitement post-sevrage ont été comparés parmi 3 groupes de veaux soit vaccinés de manière différentielle et avec un rappel avec le vaccin contre le coronavirus bovin (BCoV) disponible commercialement, soit non vaccinés contre le BCoV. Animaux: Génisses et veaux de boucherie commerciaux nés en avril et mai 2022. Procédure: En juin 2022, les veaux ont été randomisés lors du recrutement dans 3 groupes de traitement. Ceux des 2 groupes [V1 (n = 160) et V2 (n = 160)] ont reçu une dose d'amorce par voie muqueuse de l'un des deux vaccins commerciaux BCoV; ceux du 3ème groupe [CTL (n = 151)] n'étaient pas vaccinés contre le BCoV. Les groupes V1 et V2 ont eu un rappel par injection intramusculaire avant le sevrage avec le même vaccin que celui utilisé pour l'amorçage. Le sevrage a eu lieu 3 semaines après le dernier jour de conditionnement pré-sevrage. Le personnel du ranch a utilisé une définition de cas de BRD fournie par le vétérinaire de leur troupeau pour identifier, traiter et enregistrer les traitements pendant 45 jours après le sevrage. Résultats: Les taux de traitement BRD post-sevrage pour V1, V2 et CTL étaient respectivement de 7 %, 9 % et 14 %. Les veaux CTL avaient 2,2 fois plus de chances de recevoir un traitement contre la BRD que les veaux V1. Il n'y avait aucune différence dans les probabilités de traitement entre les veaux CTL et V2 ou entre les veaux V1 et V2. Conclusion: Dans un troupeau avec des cas de BRD causés par le BCoV déjà diagnostiqués, la vaccination amorce-rappel des veaux est associée à une différence de probabilité de traitement par le BRD après le sevrage par rapport à la nonvaccination des veaux contre le BCoV. Pertinence clinique: La vaccination amorce-rappel avec le vaccin commercial BCoV peut être un outil de gestion important pour les troupeaux présentant des foyers connus de BCoV BRD.(Traduit par Dr Serge Messier).

Variation in Pen-Level Prevalence of BRD Bacterial Pathogens and Antimicrobial Resistance Following Feedlot Arrival in Beef Calves.

Antimicrobials are crucial for treating bovine respiratory disease (BRD) in beef feedlots. Evidence is needed to support antimicrobial use (AMU) decisions, particularly in the early part of the feeding period when BRD risk is highest. The study objective was to describe changes in prevalence and antimicrobial susceptibility of BRD bacterial pathogens at feedlot processing (1 day on feed (1DOF)), 12 days later (13DOF), and for a subset at 36DOF following metaphylactic antimicrobial treatment. Mixed-origin steer calves (n = 1599) from Western Canada were managed as 16 pens of 100 calves, receiving either tulathromycin (n = 1199) or oxytetracycline (n = 400) at arrival. Deep nasopharyngeal swabs collected at all time points underwent culture and antimicrobial susceptibility testing (AST). Variability in the pen-level prevalence of bacteria and antimicrobial susceptibility profiles were observed over time, between years, and metaphylaxis options. Susceptibility to most antimicrobials was high, but resistance increased from 1DOF to 13DOF, especially for tetracyclines and macrolides. Simulation results suggested that sampling 20 to 30 calves per pen of 200 reflected the relative pen-level prevalence of the culture and AST outcomes of interest. Pen-level assessment of antimicrobial resistance early in the feeding period can inform the evaluation of AMU protocols and surveillance efforts and support antimicrobial stewardship in animal agriculture.

Antimicrobial resistance in generic E. coli isolated from western Canadian cow-calf herds.

Objective: To examine antimicrobial resistance (AMR) in commensal fecal Escherichia coli (E. coli) from extensively managed beef calves and cows in western Canada and describe the differences among cows and calves in the spring and fall. Animal: Beef cattle, cow-calf. Procedure: Antimicrobial susceptibility testing was conducted on generic E. coli isolates collected from 388 calves and 387 cows from 39 herds following calving in 2021, 419 calves from 39 herds near weaning, and 357 cows from 36 herds at pregnancy testing. Minimum inhibitory concentrations were measured with the NARMS CMV5AGNF plate for Gram-negative bacteria and interpreted using Clinical and Laboratory Standards Institute standard breakpoints for humans. Results: Only 16% (242/1551) of all isolates from 97% (38/39) of herds were resistant to ≥ 1 antimicrobial. Generic E. coli isolates were most commonly resistant to sulfisoxazole (11%, 175/1551), followed by tetracycline (9.3%, 145/1551) and chloramphenicol (3.5%, 55/1551). Isolates from calves in the spring were more likely to be resistant to sulfisoxazole, tetracycline, and chloramphenicol than those from cows in the spring or calves in the fall. Multiclass-resistant isolates were identified in 5% (39/807) of calves. Only 2 isolates recovered from cows were resistant to antimicrobials of very high importance for human health. Conclusion and clinical relevance: Most generic E. coli isolates were pansusceptible. The observed resistance patterns were consistent with earlier studies of AMR from commensal E. coli in this region. Baseline AMR data for cow-calf herds are not currently collected as part of routine surveillance, but are essential to inform antimicrobial use policy and stewardship.

Résistance aux antimicrobiens chez E. coli générique isolé dans des troupeaux vache-veau de l'Ouest canadien. Objectif: Examiner la résistance aux antimicrobiens (RAM) chez Escherichia coli de la flore fécale commensale (E. coli) provenant de veaux et de vaches de boucherie en élevage extensif dans l'ouest du Canada et décrire les différences entre les vaches et les veaux au printemps et à l'automne. Animal: Bovins de boucherie, vache-veau. Procédure: Des tests de sensibilité aux antimicrobiens ont été effectués sur des isolats génériques d'E. coli collectés auprès de 388 veaux et 387 vaches de 39 troupeaux après le vêlage en 2021, de 419 veaux de 39 troupeaux à l'approche du sevrage et de 357 vaches de 36 troupeaux lors des tests de gestation. Les concentrations minimales inhibitrices ont été mesurées avec la plaque NARMS CMV5AGNF pour les bactéries à Gram négatif et interprétées à l'aide des seuils standard pour les humains du Clinical and Laboratory Standards Institute. Résultats: Seulement 16 % (242/1 551) de tous les isolats provenant de 97 % (38/39) des troupeaux étaient résistants à ≥ 1 antimicrobien. Les isolats génériques d'E. coli étaient le plus souvent résistants au sulfisoxazole (11 %, 175/1 551), suivi de la tétracycline (9,3 %, 145/1 551) et du chloramphénicol (3,5 %, 55/1 551). Les isolats provenant des veaux au printemps étaient plus susceptibles d'être résistants au sulfisoxazole, à la tétracycline et au chloramphénicol que ceux provenant des vaches au printemps ou des veaux à l'automne. Des isolats résistants à plusieurs classes ont été identifiés chez 5 % (39/807) des veaux. Seuls deux isolats récupérés chez des vaches étaient résistants à des antimicrobiens de très haute importance pour la santé humaine. Conclusion et pertinence clinique: La plupart des isolats génériques d'E. coli étaient sensibles à l'ensemble des antimicrobiens. Les profils de résistance observés concordaient avec les études antérieures sur la RAM provenant d'E. coli commensal dans cette région. Les données de base sur la RAM pour les troupeaux vache-veau ne sont pas actuellement recueillies dans le cadre de la surveillance de routine, mais elles sont essentielles pour éclairer la politique et la gestion de l'utilisation des antimicrobiens.(Traduit par Dr Serge Messier).

Incidence and Risks of HIV Infection, Medication Options, and Adverse Effects in Accidental Needle Stick Injuries: A Narrative Review.

Accidental needle sticks can lead to infections, including HIV. As scientists have learned more about HIV and its replicative physiology, identification of target sites and novel medications have been developed. HIV is spread throughout the population through contact with blood, semen, and rectal or vaginal secretions of infected individuals. Therefore, it is important in general for healthcare workers to be aware of its transmission modes and ways to minimize exposure. In this regard, even with hospitals providing education, training, and safety protocols, there is a continued infection spread with HIV, especially by accidental needle sticks. There is also a wide variety of testing that can be used for HIV utilizing different methodologies, allowing for improved measurement of infection status. Any person with HIV should be tested to clarify infection status and be educated to minimize future virus spread. The current CDC recommendations for HIV infection treatment are antiretroviral therapies, such as an HIV postexposure prophylaxis regimen, which consists of a cocktail of antiretrovirals and postexposure prophylaxis immediately for occupational exposures, such as accidental needlestick exposure from an HIV infected patient. To decrease accidental HIV stick injuries, there are safety precautions in place, that if followed, would help reduce this incidence. HIV accidental needle stick injuries still happen in the hospital workplace, but with proper education and treatment, if exposed, there is hope to minimize the effects.

Antimicrobial resistance in Enterococcus isolated from western Canadian cow-calf herds.

BACKGROUND: Data on antimicrobial resistance (AMR) in cow-calf herds is limited and there have been no Canadian studies examining AMR in Enterococcus in cow-calf herds. Enterococcus is a ubiquitous Gram-positive indicator of AMR for enteric organisms that is also important in human health. The objective of this study was to describe AMR in specific Enterococcus species of interest from cow-calf herds; highlighting differences in AMR among isolates from cows and calves and samples collected in the spring and fall. Isolates (n = 1505) were examined from 349 calves and 385 cows from 39 herds in the spring of 2021 and 413 calves from 39 herds and 358 cows from 36 herds in the fall of 2021. Enterococcus species were identified using Matrix-Assisted Laser Desorption Ionization Time-Of-Flight mass spectrometry (MALDI-TOF MS) and antimicrobial susceptibility testing was completed based on a prioritization scheme for importance to human health and using the National Antimicrobial Resistance Monitoring System (NARMS) Gram positive Sensititre broth microdilution panel. RESULTS: Resistance was observed to at least one antimicrobial in 86% (630/734) of isolates from the spring and 84% (644/771) of isolates from the fall. The most common types of resistance across all species were: lincomycin, quinupristin/dalfopristin, daptomycin, ciprofloxacin, and tetracycline. However, the proportion of isolates with AMR varied substantially based on species. Multiclass resistance, defined as resistance to ≥3 antimicrobial classes after excluding intrinsic resistance, was highest in isolates from calves in the spring (6.9%) (24/349) and cows in the fall (6.7%) (24/357). Differences in resistance were seen between cows and calves in the spring and fall as well as across seasons, with no differences seen between cows and calves in the fall. CONCLUSIONS: While most Enterococcus isolates were resistant to at least one antimicrobial, questions remain regarding species differences in intrinsic resistance and the accuracy of certain antimicrobial breakpoints for specific Enterococcus spp. As a result, some species-specific AMR profiles should be interpreted with caution. Despite these constraints, Enterococcus species are important indicator organisms for AMR and resulting data can be used to inform stewardship initiatives.

Producer attitudes regarding antimicrobial use and resistance in Canadian cow-calf herds.

Objective: To describe producer attitudes toward antimicrobial use (AMU) and antimicrobial resistance (AMR), identify factors associated with attitudes, and inform stewardship initiatives. Animal: Beef cattle, cow-calf. Procedure: Cow-calf producers from the Canadian Cow-Calf Surveillance Network (C3SN) completed a survey (n = 146) on producers' attitudes toward AMU, AMR, and impacts of recent regulatory changes requiring a prescription for the purchase of medically important antimicrobials (MIA). Results: Most producers (78%, 114/146) reported being aware of initiatives to improve antimicrobial stewardship within the beef industry and 67% (97/146) indicated that AMR was a highly important issue to the industry and producers personally. Almost half of producers reported concerns that AMR development has impacted AMU decisions on their operations. Overall, veterinarians were producers' primary source of information regarding AMU, including treatment protocols, stewardship programs, and regulatory changes. Following introduction of the 2018 prescription-only regulations, 95% (138/146) of producers reported no change in AMU on their operations. Similarly, 77% (112/146) of producers reported no change in antimicrobial product access, whereas 63% (91/146) reported no change in cost. Conclusion: Most producers reported little change in access to antimicrobials and in AMU following the introduction of regulations requiring a prescription for MIA. Clinical relevance: Producers rely on veterinarians as their primary source of information regarding antimicrobial regulations and AMU. It is therefore important for veterinarians to understand their role as educators for beef cow-calf producers. Ultimately, veterinarians and producers need to work together to ensure that the health and welfare of animals are protected while using antimicrobials in a responsible manner.

Attitudes des producteurs à l'égard de l'utilisation des antimicrobiens et de la résistance dans les troupeaux vache-veau canadiens. Objectif: Décrire les attitudes des producteurs à l'égard de l'utilisation des antimicrobiens (AMU) et de la résistance aux antimicrobiens (RAM), identifier les facteurs associés à ces attitudes et les informations sur les initiatives de gouvernance. Animal: Bovins de boucherie, vache-veau. Procédure: Les producteurs naisseurs du Réseau canadien de surveillance vache-veau (C3SN) ont répondu à une enquête (n = 146) sur les attitudes des producteurs à l'égard de l'AMU, de la RAM et des impacts des récents changements réglementaires exigeant une ordonnance pour l'achat d'antimicrobiens médicalement importants (MIA). Résultats: La plupart des producteurs (78 %, 114/146) ont déclaré être au courant des initiatives visant à améliorer la gouvernance des antimicrobiens au sein de l'industrie du bœuf et 67 % (97/146) ont indiqué que la RAM était un problème très important pour l'industrie et les producteurs personnellement. Près de la moitié des producteurs ont fait part de leurs inquiétudes quant au fait que le développement de la RAM ait un impact sur les décisions d'AMU sur leurs opérations. Dans l'ensemble, les médecins vétérinaires étaient la principale source d'information des producteurs concernant l'AMU, y compris les protocoles de traitement, les programmes de gouvernance et les changements réglementaires. À la suite de l'introduction de la réglementation sur prescription uniquement en 2018, 95 % (138/146) des producteurs n'ont signalé aucun changement dans l'AMU de leurs opérations. De même, 77 % (112/146) des producteurs n'ont signalé aucun changement dans l'accès aux produits antimicrobiens, tandis que 63 % (91/146) n'ont signalé aucun changement dans le coût. Conclusion: La plupart des producteurs ont signalé peu de changements dans l'accès aux antimicrobiens et dans l'AMU par suite de l'introduction de réglementations exigeant une prescription pour le MIA. Pertinence clinique: Les producteurs comptent sur les médecins vétérinaires comme principale source d'information concernant la réglementation antimicrobienne et l'AMU. Il est donc important que les médecins vétérinaires comprennent leur rôle d'éducateurs auprès des producteurs de vaches-veaux de boucherie. En fin de compte, les médecins vétérinaires et les producteurs doivent travailler ensemble pour garantir la protection de la santé et du bien-être des animaux tout en utilisant les antimicrobiens de manière responsable.(Traduit par Dr Serge Messier).

Total and pathogen-specific serum Immunoglobulin G concentrations in neonatal beef calves, Part 1: Risk factors.

Maternal antibodies, delivered to the calf via colostrum, are crucial to prevent calfhood diseases and death. However, knowledge regarding the factors influencing this transfer of total and specific Immunoglobulin G (IgG) against common enteric and respiratory disease pathogens under current production conditions is sparse. The objectives of this study were to determine risk factors influencing total and pathogen-specific immunoglobulin G (IgG) concentrations against Escherichia coli (E. coli), bovine Rotavirus (BRoV), Cryptosporidium parvum (C. parvum), Bovine Viral Diarrhea Virus type 1 and 2 (BVDV), Parainfluenza Virus Type 3 (PI-3), Bovine Respiratory Syncytial Virus (BRSV), and Bovine Herpesvirus type 1 (BHV-1) in the serum of newborn beef calves. A total of 420 serum samples were collected from 1- to 7-day-old beef calves born on 6 farms in Alberta, Canada. Samples were analyzed by radial immunodiffusion for total IgG concentration and by enzyme-linked immunosorbent assays for pathogen-specific IgG concentrations against E. coli, BRoV, C. parvum, BVDV, PI-3, BRSV, and BHV-1. Multivariable multilevel linear and logistic regression models were built to evaluate dam- and calf-level risk factors associated with total and pathogen-specific IgG concentrations, failed transfer of passive immunity (FTPI; serum IgG < 10 g/L), and inadequate transfer of passive immunity (ITPI; serum IgG < 24 g/L). Farm was included as a random effect in all models to account for clustering at the herd level. Of the 420 calves included in this study, 5% (n = 20) and 18% (n = 75) of calves had FTPI and ITPI, respectively. Receiving colostrum intervention (i.e., being fed colostrum or colostrum product by either bottle or tube) was the most consistent risk factor for low total IgG concentration and significantly increased the odds of FTPI (Odds ratio (OR): 6.1, 95% CI: 2.0-18.9) and ITPI (OR: 4.8, 95% CI: 2.1-10.8). Calves born to cows consistently had higher pathogen-specific IgG concentrations (P < 0.0001), compared to calves born from heifers, and calves born to vaccinated dams had significantly higher BRoV, BVDV, and BHV-1-specific IgG concentrations. Interestingly, E.coli-specific IgG concentrations were associated with dam vaccination only in cows but not in heifers, which was likely due to differing vaccination strategies used. This study highlights the need to review and refine protocols with respect to dam vaccination and colostrum intervention on cow-calf operations.

Vaccine use in Canadian cow-calf herds and opportunities for improvement.

Vaccinations are one of the most impactful tools available to cow-calf producers to control within herd disease and later, in feedlots. While vaccine use has been studied across Canada, inconsistent and variable regional data makes analysis and interpretation difficult. The objective of this study was to describe vaccination protocols and factors associated with vaccine use in Canadian cow-calf herds and define associations between vaccine use and productivity outcomes. Surveys describing vaccine use in 2020 were collected from 131 cow-calf herds (40 eastern, 91 western), recruited through a national beef cattle surveillance program. Ninety-two percent of cows and replacement heifers, and 72% of bulls were vaccinated with Infectious Bovine Rhinotracheitis (IBR), Bovine Viral Diarrhea Virus (BVDV), Parainfluenza3 Virus (PI3), and Bovine Respiratory Syncytial Virus (BRSV). At least half of cows and bulls were vaccinated for clostridial pathogens and cows and heifers for viral calf scours. Clostridial vaccines were significantly more likely to be used in western Canada compared to eastern Canada. While 92% of producers vaccinated suckling calves against IBR/BRSV/PI3, only 47% provided a second vaccine prior to weaning; 78% of calves were also vaccinated at least once for BVDV before weaning. Producers who vaccinated calves against IBR/BRSV/PI3 before 3 months of age provided a second dose prior to weaning more often than producers who administer the first IBR/BRSV/PI3 vaccine later. Vaccine use has increased across Canada, particularly in calves, prior to weaning. Relative to label recommendations for annual vaccination, clostridial vaccines were generally underutilized in cows and bulls, and by producers in eastern Canada as compared to western Canada. Opportunities also exist to improve adherence to label recommendations for the booster dose of scours vaccine when used in bred replacement heifers. Protocols including product choices, the timing and boosting of respiratory vaccines in nursing calves vary widely across herds. Use of intranasal vaccines in neonatal calves less than 2 weeks old has increased in western Canada compared to previous reports. There is a need to better understand how timing of vaccination in nursing calves contributes to effectiveness, for respiratory disease in nursing and weaned calves.

Total and pathogen-specific serum Immunoglobulin G concentrations in neonatal beef calves, Part 2: Associations with health and growth.

The association of poor transfer of passive immunity (TPI) with negative health outcomes is extensively researched in dairy calves. However, few field studies have examined the effect of total and particularly pathogen-specific Immunoglobulin G (IgG) concentrations on pre-weaning health and growth of beef calves. Hence, the objective of this study was to determine the association of total and pathogen-specific IgG concentrations against selected pathogens associated with neonatal calf diarrhea (NCD) and bovine respiratory disease (BRD) and the odds of pre-weaning treatments, mortality, and the growth of newborn beef calves. A total of 420 serum samples from 1- to 7-day old beef calves born on 6 farms in Alberta, Canada, were available for this observational study. Serum samples were analyzed by radial immunodiffusion for total IgG concentration and by enzyme-linked immunosorbent assays for pathogen-specific IgG concentrations against Escherichia coli (E. coli), bovine Rotavirus (BRoV), Cryptosporidium parvum (C. parvum), Bovine Viral Diarrhea Virus (BVDV), Parainfluenza Virus Type 3 (PI-3), Bovine Respiratory Syncytial Virus (BRSV), and Bovine Herpesvirus Type 1 (BHV-1). Data about the individual dam- and calf-level risk factors, calf treatments, mortality, and birth and weaning weights were collected. Multivariable multilevel logistic and linear regression models were built to evaluate the association of total and pathogen-specific IgG concentrations with the odds of mortality and average daily gain (ADG), respectively, while their association with the odds of pre-weaning treatment was established by univariable logistic regression analysis. The odds of calves with IgG concentrations < 10 g/L of getting treated (OR 7.9, 95 % CI 2.7-23.7) and dying (OR: 18.5, 95 % CI: 3.7-93.4) were higher than for their counterparts (P < 0.0001). Calves with IgG concentrations < 24 g/L also had higher odds of dying (OR: 10.1, 95 % CI: 2.6-40.2) and had lower ADG (-0.09 kg, SE: 0.03, P < 0.002) than calves with IgG concentrations ≥ 24 g/L. Higher BVDV-specific IgG concentration was protective against mortality (OR: 0.97, 95 % CI: 0.96-0.99, P < 0.001). This study highlights the negative association of inadequate TPI with health and growth of beef calves and thus, the need to refine protocols for dam vaccination and colostrum intervention in cow-calf operations to meet these higher IgG targets.

Antimicrobial Use in Canadian Cow-Calf Herds.

Despite growing concern surrounding antimicrobial use (AMU) and the importance of cow-calf herds to the Canadian livestock industry, surveillance of AMU in cow-calf herds to inform antimicrobial stewardship programs has been sporadic. Producers from the Canadian Cow-Calf Surveillance Network (87%, 146/168) provided data and almost all reported AMU in at least one animal (99%, 145/146 herds) in 2019-2020. The most common reasons for AMU were treatment of respiratory disease in nursing calves in 78% of herds and neonatal diarrhea in 67% of herds, as well as for lameness in cows in 83% of herds. However, most herds treated <5% of animals for these reasons. Less than 2.5% of herds treated more than 30% of calves for either bovine respiratory disease or neonatal diarrhea and no herds treated more than 30% of cows for lameness. The most frequently reported antimicrobial was oxytetracycline in 81% of herds, followed by florfenicol in 73% of herds. Antimicrobials with very high importance to human health, such as ceftiofur, were used at least once by 20% of herds but were only used in >30% of nursing calves from one herd. Similarly, while 56% of herds used macrolides at least once, within-herd use was the highest in nursing calves where <4% of herds reported use in >30% of animals. Herds using artificial insemination and calving in the winter were more likely (p = 0.05) to treat >5% of nursing calves for respiratory disease, suggesting the importance of vaccination programs for herds at risk. Overall, AMU was similar to previous Canadian studies; however, the percentage of herds using macrolides had increased from a comparable study in 2014.

Integration of ITS-2 rDNA nemabiome metabarcoding with Fecal Egg Count Reduction Testing (FECRT) reveals ivermectin resistance in multiple gastrointestinal nematode species, including hypobiotic Ostertagia ostertagi, in western Canadian beef cattle.

A large-scale Fecal Egg Count Reduction Test (FECRT) was integrated with ITS-2 rDNA nemabiome metabarcoding to investigate anthelmintic resistance in gastrointestinal nematode (GIN) parasites in western Canadian beef cattle. The study was designed to detect anthelmintic resistance with the low fecal egg counts that typically occur in cattle in northern temperate regions. Two hundred and thirty-four auction market-derived, fall-weaned steer calves coming off pasture were randomized into three groups in feedlot pens: an untreated control group, an injectable ivermectin treatment group, and an injectable ivermectin/oral fenbendazole combination treatment group. Each group was divided into six replicate pens with 13 calves per pen. Individual fecal samples were taken pre-treatment, day 14 post-treatment, and at monthly intervals for six months for strongyle egg counting and metabarcoding. Ivermectin treatment resulted in an 82.4% mean strongyle-type fecal egg count reduction (95% CI 67.8-90.4) at 14 days post-treatment, while the combination treatment was 100% effective, confirming the existence of ivermectin-resistant GIN. Nemabiome metabarcoding of third-stage larvae from coprocultures revealed an increase in the relative abundance of Cooperia oncophora, Cooperia punctata, and Haemonchus placei at 14 days post-ivermectin treatment indicating ivermectin resistance in adult worms. In contrast, Ostertagia ostertagi third-stage larvae were almost completely absent from day 14 coprocultures, indicating that adult worms of this species were not ivermectin resistant. However, there was a recrudescence of O. ostertagi third stage larvae in coprocultures at three to six months post-ivermectin treatment, which indicated ivermectin resistance in hypobiotic larvae. The calves were recruited from the auction market and, therefore, derived from multiple sources in western Canada, suggesting that ivermectin-resistant parasites, including hypobiotic O. ostertagi larvae, are likely widespread in western Canadian beef herds. This work demonstrates the value of integrating ITS-2 rDNA metabarcoding with the FECRT to enhance anthelmintic resistance detection and provide GIN species- and stage-specific information.

Effects of naturally acquired gastrointestinal nematode infection on bovine viral diarrhea virus vaccine-directed antibody response in western Canadian feedlot cattle.

Objective: To determine how gastrointestinal nematode (GIN) infection, reflected by fecal egg counts and Ostertagia ostertagi serum antibody titers, is associated with the antibody response to bovine viral diarrhea virus type 1 (BVDV-1) vaccine antigen in fall-weaned feedlot cattle from western Canada. Animals: Cross-sectional study with 240 steer calves derived from an auction market. Procedure: At feedlot arrival, calves were given a commercial vaccine containing modified live BVDV-1. Serum neutralization antibody titers against BVDV-1 antigens were determined in individual blood samples collected pre-vaccination and 21 d after vaccination. A modified Wisconsin sugar floatation method was used to obtain individual calf GIN egg counts in fecal samples on arrival. Antibody titers against O. ostertagi were determined using an enzyme-linked immunosorbent assay in on-arrival blood samples. Results: Fecal egg counts and O. ostertagi titers were not associated with vaccine antibody-fold changes. Similarly, fecal egg counts and O. ostertagi titers were not associated with vaccine-induced seroconversion. Conclusions: The relatively low GIN burdens, reflected by the overall low fecal egg counts in these fall-weaned feedlot calves, did not have measurable adverse effects on the humoral immune response to BVDV-1 vaccine antigens. Clinical relevance: An adequate response to vaccination is important for cattle welfare and productivity. Conditions that negatively affect this response may vary regionally, such as GIN infection. Understanding this is essential. Although subclinical intestinal parasitism did not noticeably affect the antibody response in these steers, higher GIN burdens and actual immune protection from clinical disease remain to be investigated.

Effets d'une infection par des nématodes gastro-intestinaux d'origine naturelle sur la réponse en anticorps dirigés par le vaccin contre le virus de la diarrhée virale bovine chez les bovins des parcs d'engraissement de l'Ouest canadien. Objectif: Déterminer comment l'infection par les nématodes gastro-intestinaux (GIN), reflétée par le nombre d'oeufs fécaux et les titres d'anticorps sériques d'Ostertagia ostertagi, est associée à la réponse en anticorps à l'antigène du vaccin contre le virus de la diarrhée virale bovine de type 1 (BVDV-1) chez les bovins en parc d'engraissement sevrés à l'automne de l'Ouest canadien. Animaux: Étude transversale auprès de 240 veaux bouvillons issus d'un marché aux enchères. Procédure: À leur arrivée au parc d'engraissement, les veaux ont reçu un vaccin commercial contenant du BVDV-1 vivant modifié. Les titres d'anticorps sériques neutralisants contre les antigènes BVDV-1 ont été déterminés dans des échantillons de sang individuels prélevés avant la vaccination et 21 jours après la vaccination. Une méthode de Wisconsin modifiée de flottation au sucre a été utilisée pour obtenir le nombre d'oeufs GIN de chaque veau dans les échantillons fécaux à l'arrivée. Les titres d'anticorps dirigés contre O. ostertagi ont été déterminés à l'aide d'un dosage immuno-enzymatique dans des échantillons de sang à l'arrivée. Résultats: Le nombre d'oeufs fécaux et les titres d'O. ostertagi n'étaient pas associés aux modifications du titre d'anticorps vaccinaux. De même, le nombre d'oeufs fécaux et les titres d'O. ostertagi n'étaient pas associés à la séroconversion induite par le vaccin. Conclusion: Les charges relativement faibles de GIN, reflétées par le faible nombre global d'oeufs fécaux chez ces veaux d'engraissement sevrés à l'automne, n'ont pas eu d'effets indésirables mesurables sur la réponse immunitaire humorale aux antigènes du vaccin BVDV-1. Pertinence clinique: Une réponse adéquate à la vaccination est importante pour le bien-être et la productivité des bovins. Les conditions qui affectent négativement cette réponse peuvent varier selon les régions, telles que l'infection par les GIN. Comprendre cela est essentiel. Bien que le parasitisme intestinal subclinique n'ait pas sensiblement affecté la réponse en anticorps chez ces bouvillons, des charges de GIN plus élevées et une protection immunitaire réelle contre la maladie clinique restent à étudier.(Traduit par Dr Serge Messier).

Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review.

Benign Prostatic Hyperplasia (BPH) is a prevalent condition that affects aging men, leading to the development of lower urinary tract symptoms (LUTS) and potentially severe complications such as complete obstruction. The management of BPH typically involves the use of medications from different classes, including alpha-1 antagonists, 5-alpha reductase inhibitors, and anticholinergics. Combination therapy utilizing drugs from different classes can also effectively manage the BPH-LUTS complex. Recent research has revealed that phosphodiesterase 5 (PDE5) inhibitors, including Tadalafil and Sildenafil, are highly effective in treating LUTS associated with BPH. Tadalafil as a monotherapy has recently been shown to significantly improve LUTS in BPH patients. Additionally, the use of herbal remedies as a treatment option for BPH has also been widely debated. Previous research suggests that saw palmetto can reduce BPH symptoms through several proposed mechanisms, but recent trials have found inconsistencies in its efficacy. In this literature review, we conducted an extensive PubMed database search to provide current and comprehensive insights into BPH treatment options. This review comprehensively evaluates available treatments for managing BPH, highlighting the effectiveness of different classes of medications and combination therapies in managing associated symptoms. The present investigation also discusses recent research on the efficacy of PDE5 inhibitors in treating LUTS associated with BPH and the uncertain efficacy of herbal remedies. The insights provided by this study can guide healthcare professionals in making informed decisions about managing BPH, ultimately improving patient outcomes.

Antimicrobial resistance in bovine respiratory disease: Auction market- and ranch-raised calves.

This study compared changes in prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in feedlot calves derived from the auction market (AUCT; n = 299) and from a single-ranch source (RANCH; n = 300). In the AUCT calves, the prevalence of Mannheimia haemolytica decreased, whereas Histophilus somni increased over the feeding period. The AUCT calves showed an increase in isolates not susceptible to tulathromycin for all bovine respiratory disease (BRD) pathogens, an increase in Pasteurella multocida and Histophilus somni isolates not susceptible to oxytetracycline, and an increase in Pasteurella multocida isolates not susceptible to florfenicol. In the RANCH calves, the prevalence of all 3 BRD pathogens was high at feedlot entry and decreased significantly during the study period. In RANCH calves, there was a significant increase in Pasteurella multocida isolates not susceptible to oxytetracycline, tulathromycin, and florfenicol. Surprisingly, there was a significant decrease in Mannheimia haemolytica isolates that were not susceptible to oxytetracycline, tilmicosin, and tulathromycin.

Résistance aux antimicrobiens lors de maladies respiratoires bovines : veaux provenant de marché aux enchères et ceux élevés en ranch. Cette étude a comparé les changements dans la prévalence et la sensibilité aux antimicrobiens de Mannheimia haemolytica, Pasteurella multocida et Histophilus somni isolés de veaux en parc d'engraissement provenant du marché aux enchères (AUCT; n = 299) et d'un seul ranch (RANCH; n = 300). Chez les veaux AUCT, la prévalence de M. haemolytica a diminué, tandis que celle d'H. somni a augmenté au cours de la période d'alimentation. Les veaux AUCT ont montré une augmentation des isolats non sensibles à la tulathromycine pour tous les agents pathogènes des maladies respiratoires bovines (BRD), une augmentation des isolats de P. multocida et H. somni non sensibles à l'oxytétracycline, et une augmentation des isolats de P. multocida non sensibles au florfénicol. Chez les veaux du RANCH, la prévalence des 3 agents pathogènes BRD était élevée à l'entrée du parc d'engraissement et a diminué de manière significative au cours de la période d'étude. Chez les veaux RANCH, il y a eu une augmentation significative des isolats de P. multocida non sensibles à l'oxytétracycline, à la tulathromycine et au florfénicol. Étonnamment, il y a eu une diminution significative des isolats de M. haemolytica qui n'étaient pas sensibles à l'oxytétracycline, à la tilmicosine et à la tulathromycine.(Traduit par Dr Serge Messier).

Biosecurity practices in western Canadian cow-calf herds and their association with animal health.

Biosecurity practices of beef cow-calf herds in western Canada have not been studied extensively nor is there a good understanding of their association with herd health. A survey was sent to 103 cow-calf producers of the Western Canadian Cow-Calf Surveillance Network. Eighty completed questionnaires were returned. Bulls were purchased for all herds during the 2014 to 2017 study period; 54% of herds purchased heifers and 42% purchased cows. The use of standard biosecurity practices was generally low with 30% of producers keeping purchased animals separate and 30% vaccinating new additions. None of the evaluated biosecurity practices were associated with reporting Johne's disease. The purchase of > 10 bulls, the purchase of cows, not vaccinating animals bought into the herd, and use of community pasture were associated with a bovine respiratory disease outbreak. Outbreaks of calf diarrhea were associated with the purchase of 10 or more bulls, the use of a community pasture, and leasing or sharing bulls.

Pratiques de biosécurité dans les troupeaux de vaches-veaux de l'Ouest canadien et leur association avec la santé animale. Les pratiques de biosécurité des troupeaux de bovins de boucherie de l'Ouest canadien n'ont pas fait l'objet d'études approfondies et il n'y a pas de bonne compréhension de leur association avec la santé du troupeau. Un sondage a été envoyé à 103 producteurs de vaches-veaux du Réseau de surveillance vache-veau de l'Ouest canadien. Quatre-vingts questionnaires remplis ont été retournés. Des taureaux ont été achetés pour tous les troupeaux au cours de la période d'étude 2014 à 2017; 54 % des troupeaux ont acheté des génisses et 42 % des vaches. L'utilisation des pratiques de biosécurité standard était généralement faible, 30 % des producteurs gardant les animaux achetés séparés et 30 % vaccinant les nouveaux ajouts. Aucune des pratiques de biosécurité évaluées n'était associée à la déclaration de la maladie de Johne. L'achat de plus de 10 taureaux, l'achat de vaches, et la non-vaccination d'animaux incorporés dans le troupeau, et l'utilisation de pâturages communautaires ont été associés à une épidémie de maladie respiratoire bovine. Les flambées de diarrhée des veaux étaient associées à l'achat de 10 taureaux ou plus, à l'utilisation d'un pâturage communautaire et à la location ou au partage de taureaux.(Traduit par Dr Serge Messier).

Gastrointestinal nematode prevalence and fecal egg counts in beef cattle from western Canada.

Fecal samples were collected from cows (n = 1458), calves (n = 1188), and replacement heifers (n = 921) between 2012 and 2014 from 199 herds and generalized estimating equations were used to predict mean fecal egg counts and prevalence of egg-positive samples. Replacement heifers had the highest prevalence of Trichostrongylid-type eggs at 83% [95% confidence interval (CI): 78% to 87%], and cows had the lowest at 75% (95% C: 70% to 81%). Nematodirus spp. was most frequently present in calves [predicted prevalence: 34% (95% CI: 28% to 40%)]. Mean fecal egg counts were highest in calves with 5.9 (95% CI: 3.9 to 7.8) Trichostrongylid-type eggs per gram (EPG) of feces and 1.0 (95% CI: 0.7 to 1.4) Nematodirus spp. EPG. Although mean egg counts were low to moderate, the high prevalence highlights the need to further investigate the epidemiology of gastrointestinal nematodes in western Canada. This is particularly relevant considering management changes, increasing herd sizes, climate change, and threatening anthelmintic resistance.

Prévalence des nématodes gastro-intestinaux et dénombrements des oeufs dans les fèces chez les bovins d'embouche dans l'ouest canadien. Des échantillons de fèces furent prélevés de vaches (n = 1458), veaux (n = 1188) et génisses de remplacement (n = 921) entre 2012 et 2014 dans 199 troupeaux et des équations d'estimation généralisée furent utilisées pour prédire les dénombrements moyens d'oeufs dans les fèces et la prévalence d'échantillons positifs pour la présence d'oeufs. Les génisses de remplacement avaient la prévalence la plus élevée d'oeufs de type Trichostrongylide avec 83 % [intervalle de confiance 95 % (IC) : 78 % à 87 %], et les vaches avaient la plus faible avec 75 % (95 % IC : 70 % à 81 %). Les Nematodirus spp. étaient présents le plus fréquemment chez les veaux [prévalence prédite : 34 % (95 % IC : 28 % à 40 %)]. Les dénombrements moyens d'oeufs dans les fèces étaient les plus élevés chez les veaux avec 5,9 (95 % IC : 3,9 à 7,8) oeufs de type Trichostrongylide par gramme (EPG) de fèces et 1,0 (95 % IC : 0,7 à 1,4) EPG de Nematodirus spp. Bien que les dénombrements moyens d'oeufs étaient faibles à modérés, la prévalence élevée met en évidence le besoin de continuer d'examiner l'épidémiologie des nématodes gastro-intestinaux dans l'ouest du Canada. Ceci est particulièrement approprié considérant les changements dans la gestion, l'augmentation de la taille des troupeaux, les changements climatiques et la menace de la résistance aux produits anthelmintiques.(Traduit par Dr Serge Messier).

Gastrointestinal nematode management in western Canadian cow-calf herds.

There is a paucity of information from western Canadian beef cow-calf producers about how they control gastrointestinal nematodes. The objectives of this study were to describe cow-calf producers' management practices related to control of gastrointestinal nematodes including pasture management and use of parasite control products. A questionnaire was distributed to 105 producers in May 2015. Responses from 97 producers revealed the almost uniform dependence on the use of a pour-on macrocyclic lactone parasite control product in the fall as part of a routine farm management program. Control of external parasites was the primary reason for treatment, while none of the producers chose to treat specifically to manage internal parasites. The predominant management practices identified through this study increase the risk of development of anthelmintic resistance. The results also highlight the need to raise awareness of the importance of an evidence-based gastrointestinal nematode control program in beef cow-calf herds.

Gestion des nématodes gastro-intestinaux dans les troupeaux vaches-veaux de l'ouest canadien. Il y a une rareté d'informations provenant des producteurs de vaches-veaux de l'ouest canadien sur la façon dont ils maitrisent les nématodes gastro-intestinaux. Les objectifs de la présente étude étaient de décrire les pratiques de gestion des producteurs de vaches-veaux relativement à la maitrise des nématodes gastro-intestinaux incluant la gestion des pâturages et l'utilisation des produits antiparasitaires. Un questionnaire fut distribué à 105 producteurs en mai 2015. Des réponses en provenance de 97 producteurs ont révélé la dépendance presque généralisée sur l'utilisation d'un produit antiparasitaire à verser sur l'animal à base de lactone macrocyclique à l'automne comme faisant partie d'un programme de routine de gestion à la ferme. La maitrise des parasites externes était la principale raison pour le traitement, alors qu'aucun des producteurs n'avait choisi de traiter spécifiquement pour gérer les parasites internes. Les pratiques de gestion prédominantes identifiées dans la présente étude augmentent le risque de développement de résistance aux anthelmintiques. Les résultats mettent également en lumière le besoin d'augmenter la sensibilisation de l'importance d'une approche factuelle à un programme de gestion des nématodes dans les troupeaux vaches-veaux.(Traduit par Dr Serge Messier).

Correction: Identifying performance benchmarks and determinants for reproductive performance and calf survival using a longitudinal field study of cow-calf herds in western Canada.

[This corrects the article DOI: 10.1371/journal.pone.0219901.].

Identifying performance benchmarks and determinants for reproductive performance and calf survival using a longitudinal field study of cow-calf herds in western Canada.

The cow-calf industry in North America is in a period of rapid consolidation with corresponding increases in herd sizes and changes in management. The objectives of this study were to examine longitudinal data on reproductive performance in cow-calf herds and identify benchmarks for the most critical measures and important sources of differences among herds. To address these questions, a surveillance network was established in western Canada to collect data between 2013 to 2017 privately owned cow-calf herds during calving (n = 105 herds) and at pregnancy testing (n = 94 herds). Data were summarized for a number of indices of herd performance. However, the values considered to be most reliable and accurate were the percentage of females not pregnant when tested by a veterinarian, the percentage of calves dead within 24 hours of birth, and the percentage of calves dead from 24 hours to weaning. The mean and variation between herds for heifers, measured using standard deviation, was greater than for cows for: non-pregnancy (cows 6.8% (mean)±3.4%(SD), heifers 9.7%±8.2%), calf death from birth to 24 hours (cows 2.1%±1.6%, heifers 3.6%±4.5%), and calf death from 24 hours to weaning (cows 2.5%±2.4%, heifers 2.9%±3.9%). Benchmarks or performance targets derived from the 25th percentiles of these data for both cows and heifers were <5% for non-pregnancy risk and <1% for calf loss within 24 hours of birth. The suggested benchmark for calf loss from 24 hours to weaning was <2% for cows and <1% for heifers. All outcomes consistently displayed greater variation between herds as compared to year to year differences within herds with the exception of calf loss before 24 hours in cows. The timing of the start of breeding season was a consistent source of variation in risks of non-pregnancy and calf losses. Cows bred in April or earlier to start calving in late December or January were at increased risk of low pregnancy percentages (p<0.001) and calf losses at birth (p<0.04), as well as increased calf loss before weaning in both cows and heifers (p<0.02). There was also an increase in the risk of non-pregnancy for cows and heifers (p<0.001) where first exposure to breeding was not until July or August. In contrast, the risks of calf loss within 24 hrs of birth (p<0.001) and from 24 hrs to weaning in cows (p<0.02) first exposed to breeding in July and August were significantly lower than for herds that had earlier breeding seasons.

Antimicrobial resistance in fecal Escherichia coli and Campylobacter spp. from beef cows in western Canada and associations with herd attributes and antimicrobial use.

The objectives of this study were to describe the frequency of antimicrobial resistance (AMR) in Escherichia coli and Campylobacter spp. isolates in fecal samples from beef cow-calf herds and to examine the associations between herd management practices, reported antimicrobial use, and AMR. Baseline prevalence data are needed to evaluate the effectiveness of antimicrobial stewardship programs. A pooled fecal sample, representing 20 cows, was collected from each of 107 herds during pregnancy testing. In the 305 recovered E. coli isolates (maximum 3 per herd), resistance to ≥ 1 antimicrobial was identified in 12 isolates [4%, 95% confidence interval (CI): 2% to 7%] from 105 herds (11%, 95% CI: 7% to 19%). The most common resistances identified in E. coli isolates were to tetracycline (3%) and to both streptomycin and sulfisoxazole (3%). Only 1 E. coli isolate was resistant to an antimicrobial of very high importance to human health - amoxicillin/clavulanic acid. However, 2 E. coli isolates had intermediate susceptibility to ciprofloxacin. Resistance to 1 antimicrobial was identified in 16 of 87 Campylobacter spp. isolates (18%, 95% CI: 11% to 28%) from 87 herds. Resistance to tetracycline was reported in 15% of Campylobacter spp. isolates and to nalidixic acid in 3.4%. Herds in which cows were treated with florfenicol were more likely to have E. coli resistance to ≥ 2 antimicrobials (OR 7.1, 95% CI: 1.1 to 57, P = 0.03). Herds with calf mortality of > 5% were more likely to have E. coli with resistance to streptomycin and sulfisoxazole [odds ratio (OR): 7.8, P = 0.03]. The results of this study are consistent with previous reports from western Canada and provide a starting point for designing an ongoing antimicrobial surveillance program.

Les objectifs de la présente étude étaient de décrire la fréquence de résistance antimicrobienne (RAM) chez des isolats d'Escherichia coli et de Campylobacter spp. provenant d'échantillons fécaux de troupeaux bovins de type vache-veau et d'examiner les associations entre les pratiques de conduite d'élevage, l'utilisation rapportée d'antimicrobiens, et la RAM. Des données de prévalence de base sont requises afin d'évaluer l'efficacité de programmes de gérance des antimicrobiens. Un échantillon fécal regroupé, représentant 20 vaches, fut prélevé de chacun des 107 troupeaux durant la vérification des gestations. Parmi les 305 isolats d'E. coli obtenus (maximum de 3 par troupeau), de la résistance envers ≥ 1 antimicrobien a été identifiée chez 12 isolats [4 %, intervalle de confiance (IC) 95 % : 2 % à 7 %] de 105 troupeaux (11 %, IC 95 % : 7 % à 19 %). Les résistances les plus fréquemment identifiées parmi les isolats d'E. coli était envers la tétracycline (3 %) ainsi que la streptomycine et le sulfisoxazole (3 %). Seulement un isolat d'E. coli était résistant à un antimicrobien de très haute importance en médecine humaine, soit à l'amoxicilline/acide clavulanique. Toutefois, deux isolats d'E. coli avaient une sensibilité intermédiaire au ciprofloxacin. De la résistance envers un antimicrobien fut identifiée chez 16 des 87 isolats de Campylobacter spp. (18 %, IC 95 % : 11 % à 28 %) de 87 troupeaux. La résistance à la tétracycline a été rapportée dans 15 % des isolats de Campylobacter spp. et à l'acide nalidixique chez 3,4 %. Les troupeaux parmi lesquels les vaches furent traitées avec du florfénicol étaient plus susceptibles d'avoir des isolats d'E. coli résistants à ≥ deux antimicrobiens [rapport de cotes (RC) : 7,1, IC 95 % : 1,1 à 57, P = 0,03]. Les troupeaux avec une mortalité des veaux > 5 % étaient plus susceptibles d'avoir des E. coli avec une résistance à la streptomycine et au sulfisoxazole (RC : 7,8, P = 0,03). Les résultats de la présente étude sont cohérents avec des rapports antérieurs provenant de l'ouest canadien et fournissent un point de départ pour concevoir un programme de surveillance de la résistance antimicrobienne.(Traduit par Docteur Serge Messier).